Rapamycin has brought a new dawn to cancer treatment due to its special mechanism of inhibiting cancer cell growth via inhibition of the mammalian target of rapamycin (mTOR), which is the key factor in cell proliferation regulation [4]. This evidence concerns the gene MTOR and cancer.